Roger Pebody

4 weeks ago | portugues.medscape.com | Roger Pebody

Pesquisadores suíços descreveram que um modelo de inteligência artificial (IA) que utiliza dados coletados rotineiramente foi capaz de prever a ocorrência subsequente de tuberculose ativa. O modelo de IA superou os exames biológicos para infecção latente pela tuberculose (ILTB) na identificação de pacientes vivendo com vírus da imunodeficiência humana (HIV) sob alto risco de apresentar tuberculose.

1 month ago | thelancet.com | Roger Pebody

In a provincial Mexican city, a young gay man wakes up on a Saturday morning, recalls the events of the previous night and realises that he needs post-exposure prophylaxis (PEP). He's not sure if he can get it locally, especially with health services closed for the weekend, and he's worried about doctors judging him. As he only knows about PEP from Instagram posts by a group called VIHve Libre , he sends them a message.

1 month ago | medscape.com | Roger Pebody

An artificial intelligence (AI) model using routinely collected data predicted subsequent development of active tuberculosis (TB), Swiss researchers reported. The AI model outperformed biological tests for latent TB in identifying HIV-positive patients at high risk of developing TB. As well as immune function and sociodemographic variables, the AI model retained several biomarkers indicative of patients’ well-being and metabolism.

Mar 20, 2025 | aidsmap.com | Roger Pebody

Estimated reading time 3 minutes While some countries have already shifted to less intensive monitoring requirements for PrEP users, a Dutch study has now provided evidence that it’s OK to test for sexually transmitted infections (STIs) every six months, to have clinic appointments at the same rhythm and for services to be delivered online. Simplified, less burdensome services had just as good outcomes as the standard of care.

Mar 5, 2025 | espanol.medscape.com | Roger Pebody

Una calculadora de riesgo cardiovascular utilizada habitualmente por los profesionales médicos subestima el riesgo para las mujeres y las personas afrodescendientes que viven con infección por virus de inmunodeficiencia humana en los países de ingresos altos, mientras que sobreestima el riesgo para las personas con dicho virus en los países de ingresos bajos y medios.[1] Las puntuaciones de riesgo son un factor clave en las recomendaciones de las guías para la prescripción de estatinas y...